Vanessa Garcia Moreira

Vanessa Garcia Moreira

Auto-generated profile, based on publicly available information

Vanessa Garcia Moreira

Servicio de Análisis Clínicos, Hospital Universitario de Cabueñes, Gijón, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
VMVanessa Garcia Moreira
Vanessa Garcia Moreira
NVNana Beridze Vaktangova
Nana Beridze Vaktangova
MGMaria Dolores Martinez Gago
Maria Dolores Martinez Gago
BGBelen Laborda Gonzalez
Belen Laborda Gonzalez
SASara Garcia Alonso
Sara Garcia Alonso
EREloy Fernandez Rodriguez
Eloy Fernandez Rodriguez
Usually serum albumin is measured with dye‐binding assay as bromocresol green (BCG) and bromocresol purple (BCP) methods. The aim of this paper was to examine the differences in albumin measurements between the Advia2400 BCG method (AlbBCG), Dimension RxL BCP (AlbBCP) and capillary zone electrophoresis (CZE). Albumin concentrations from 165 serum samples were analysed using AlbBCG, AlbBCP and CZE. CZE was employed to estimate different serum protein fractions. Influence of globulins on albumin concentration discrepancies between methods was estimated as well as the impact of the albumin method on aCa concentrations. Medcalc was employed for statistical analysis, setting a value of P < 0.05 as significant. Correlation of AlbBCG and AlbBCP was r = 0.948 (p < 0.0001), but mean difference was large. Bland-Altman plots showed greater bias at lower albumin concentrations. AlbBCG were positively biased versus CZE (3.54 g/L). There was good agreement between CZE and ALbBCP (< 1 g/L). The AlbBCG assay bias shows a good correlation with alpha-1-globulin concentrations (r = 0.758); moderate and weak correlations were observed with CRP (r = 0.729) and alpha-2-globulin (r = 0.585); we found no correlation with beta-globulin (r = 0.120) or gamma-globulin (r = –0.303). Mean aCa based on AlbBCG and AlbBCP methods were 2.34 ± 0.15 mmol/L and 2.46 ± 0.16 mmol/L (p < 0.01), with a mean BCG-BCP difference of –0.12. Albumin results from the BCP and BCG methods may result in unacceptable differences and clinical confusion, especially at lower albumin concentrations. Serum acute phase proteins contribute to overestimating the albumin concentration using AlbBCG.

16 April 2022 in Advances in Hematology
Verified
Journal Article
Open access
PDF file
FCFrancisco Javier Cepeda-Piorno
Francisco Javier Cepeda-Piorno
EGEsther González-García
Esther González-García
AMAlba Méndez-Gallego
Alba Méndez-Gallego
JTJuan Torres-Varona
Juan Torres-Varona
VGVanesa García-Moreira
Vanesa García-Moreira
SGSegundo Gonzalez
Segundo Gonzalez
Objectives. The aim of this study was to compare the creatinine equations with cystatin C (CysC) equations to define renal impairment (RI) in newly diagnosed multiple myeloma (MM) patients and to analyse the equation that allows for identifying patients with more and worse prognostic factors. Methods. Renal function was evaluated prospectively in 61 patients with newly diagnosed untreated MM employing CKD-EPI and CAPA equations. The comparison was conducted using BlandAltman graphics and Cohens Kappa statistic. MannWhitney T and Chi-square tests were used, and univariate and multivariate analyses were carried out. Results. According to the IMWG criteria, 26 of patients showed RI (3 women/13 men) whilst the use of CysC equations allowed us to identify up to 39 of patients (7 women/17 men). The CAPA equation was less biased and dispersed and more sensitive than CKD-EPI-creatinine. Furthermore, univariate analysis unveiled an association between decreased CKD-EPI-CysC and poor prognosis based on R-ISS-3. Conclusions. The IMWG criteria may underestimate kidney disease, mostly in women, which could affect the dose received as well as its toxicity. Altogether, our data suggest that equations that include CysC are more accurate to detect hidden kidney disease, as well as patients with more and worse prognostic factors, in newly diagnosed MM.